Perinatal infections and brain injury: current treatment options (Q35040309)

6 August 2017

1 reference

title

Perinatal infections and brain injury: current treatment options (English)

1 reference

6 August 2017

Pablo J Sánchez

1 reference

6 August 2017

publication date

1 December 2002

1 reference

6 August 2017

published in

Clinics in Perinatology

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

799-826

1 reference

Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Early-Onset Neonatal Sepsis in the Era of Group B Streptococcal Prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Long-term sequelae of group B streptococcal meningitis in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Once daily dosing of gentamicin in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy. Report of the neonatal meningitis cooperative study group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Gram-negative enteric bacillary meningitis: a twenty-one-year experience

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Steroid therapy for bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

A practical approach to evaluating and treating neutropenia in the neonatal intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Late-onset meningitis in sick, very-low-birth-weight infants. Clinical and sonographic observations

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Perinatal transmission of Ureaplasma urealyticum: current concepts based on review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Transmission of Ureaplasma urealyticum from mothers to full and preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Vertical transmission of Ureaplasma urealyticum in full term infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Ureaplasma urealyticum colonization of full term infants: perinatal acquisition and persistence during early infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

VaginalUreaplasma urealyticum colonization: Influence on pregnancy outcome and neonatal morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Neonatal meningitis caused by Ureaplasma urealyticum

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Mycoplasma hominis. A cause of neonatal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Frequency and significance of isolation of Ureaplasma urealyticum and Mycoplasma hominis from cerebrospinal fluid and tracheal aspirate specimens from low birth weight infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Ureaplasma urealyticum in the cerebrospinal fluid of a premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Meningitis in a newborn infant caused by Mycoplasma hominis.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Mycoplasma hominis meningitis in a preterm infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Mycoplasma hominis meningitis in a premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Ureaplasma urealyticum cultured from brain tissue of preterm twins who died of intraventricular hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Ureaplasma and mycoplasma infections of the central nervous system in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Neonatal central nervous system infection due to Mycoplasma hominis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Mycoplasma hominis and Ureaplasma urealyticum in neonates with suspected infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Mycoplasmal infections of cerebrospinal fluid in newborn infants from a community hospital population.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Chronic Ureaplasma urealyticum and Mycoplasma hominis infections of central nervous system in preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Therapeutic considerations for Ureaplasma urealyticum infections in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Meningo-encephalitis in a neonate caused by maternal Mycoplasma hominis treated successfully with chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Serum concentrations of erythromycin after intravenous infusion in preterm neonates treated for Ureaplasma urealyticum infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Pituitary gland gumma in congenital syphilis after failed maternal treatment: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Neonatal hypoglycemia caused by hypopituitarism in infants with congenital syphilis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Survival with hypopituitarism from congenital syphilis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Central nervous system infection in congenital syphilis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Infantile multisystem inflammatory disease: another case of a new syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Lyme disease during pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Natural history of neonatal herpes simplex virus infections in the acyclovir era.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Safety and Efficacy of High-Dose Intravenous Acyclovir in the Management of Neonatal Herpes Simplex Virus Infections

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Acyclovir therapy in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Herpes simplex virus encephalitis in children: analysis of cerebrospinal fluid and progressive neurodevelopmental deterioration

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Outcome in children with enteroviral meningitis during the first year of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Severe neonatal enteroviral hepatitis treated with pleconaril

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Single dose pharmacokinetics of pleconaril in neonates. Pediatric Pharmacology Research Unit Network

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Progressive rubella panencephalitis. Late onset after congenital rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Congenital lymphocytic choriomeningitis virus infection in twins.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Candida parapsilosis meningitis in a premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Candidal meningitis in neonates: a 10-year review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Pharmacokinetics of amphotericin B in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Successful treatment of Candida meningitis with amphotericin B and 5-fluorocytosine in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Synergism of Amphotericin B and 5-Fluorocytosine for Candida Species

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Fluconazole monotherapy for candidal meningitis in a premature infant

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Itraconazole therapy for disseminated candidiasis in a very low birthweight neonate

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Liposomal amphotericin B treatment for neonatal fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Subclinical central nervous system disease of neonates: a prospective study of infants born with increased levels of IgM.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Intellectual deficits in children born with subclinical congenital toxoplasmosis: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Congenital toxoplasmosis. Clinical and neuroradiological evaluation of the cerebral lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Results of 20-year follow-up of congenital toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Absence of Sensorineural Hearing Loss in Treated Infants and Children with Congenital Toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Levels of pyrimethamine in sera and cerebrospinal and ventricular fluids from infants treated for congenital toxoplasmosis. Toxoplasmosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

Congenital malaria in a preterm neonate: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2802%2900050-7

7 January 2021

10.1016/S0095-5108(02)00050-7

Identifiers

DOI

1 reference

6 August 2017

1 reference